Ro 19-1400 structure
|
Common Name | Ro 19-1400 | ||
|---|---|---|---|---|
| CAS Number | 122937-55-7 | Molecular Weight | 616.85000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C31H56N2O8S | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of Ro 19-1400Ro 19-1400 is a platelet-activating factor antagonist that directly inhibits immunoglobulin E-dependent mediator release[1]. |
| Name | [(2R)-2-methoxycarbonyloxy-3-(octadecylcarbamoyloxy)propyl] 4-(1,3-thiazol-3-ium-3-yl)butanoate,hydroxide |
|---|---|
| Synonym | More Synonyms |
| Description | Ro 19-1400 is a platelet-activating factor antagonist that directly inhibits immunoglobulin E-dependent mediator release[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C31H56N2O8S |
|---|---|
| Molecular Weight | 616.85000 |
| Exact Mass | 616.37600 |
| PSA | 147.83000 |
| LogP | 7.51090 |
| 3-(4-(2-((Methoxycarbonyl)oxy)-3-(((octadecylamino)carbonyl)oxy)propoxy)-4-oxobutyl)-,hydroxide,(R)-thiazolium |
| Thiazolium,3-(4-(2-((methoxycarbonyl)oxy)-3-(((octadecylamino)carbonyl)oxy)propoxy)-4-oxobutyl)-,hydroxide,(R) |
| Ro-19-1400 |
| [(2R)-2-methoxycarbonyloxy-3-(octadecylcarbamoyloxy)propyl] 4-(1,3-thiazol-3-ium-3-yl)butanoate hydroxide |